Kraig Biocraft Laboratories Shareholder Conference Call Today, Friday, October 8, 2010
October 08 2010 - 6:05AM
Marketwired
Kraig Biocraft Laboratories, Inc. (PINKSHEETS: KBLB) reminds all
current, new and prospective shareholders that the Company's CEO
will conduct a shareholder conference call today, Friday, October
8, 2010 at 4:30 p.m. EDT.
Kim Thompson, the Company's CEO and founder, will review the
recent development of recombinant spider silk technology, the
Company's intellectual property and commercialization rights to
this technology, as well as what is in the research and development
pipeline.
Interested parties should dial the toll-free numbers below in
the order provided. If the first number does not connect, please
dial the next number below.
1. 866-906-9888 and when prompted enter access code 3535794
followed by the # (pound) sign.
2. 866-506-1209 and when prompted enter access code 3535794
followed by the # (pound) sign.
3. 866-939-8416 and when prompted enter access code 3535794
followed by the # (pound) sign.
It is recommended that callers dial in approximately five
minutes before the conference is scheduled to begin.
Shareholders are invited to submit questions to benh@ttfsco.com
prior to noon today. For interested parties who are unable to make
today's call, the Company anticipates posting a recording of the
conference call on the Company website sometime in the near
future.
All interested parties are encouraged by the Company to use the
following link to view a video of the public announcement
concerning the recent scientific breakthrough in order to be
prepared for the conference call.
http://www.youtube.com/watch?v=GnUupDb2Mvo
Additional information is available on Kraig Biocraft
Laboratories (KBLB) (PINKSHEETS: KBLB) web site:
http://www.KraigLabs.com.
Conference call: 4:30 p.m. EDT (Eastern Daylight Time) today,
Friday, October 8, 2010.
Statements in this press release about the company's future and
expectations other than historical facts are "forward-looking
statements." These statements are made on the basis of management's
current views and assumptions. As a result, there can be no
assurance that management's expectations will necessarily come to
pass. These forward-looking statements generally can be identified
by phrases such as "believes," "plans," "expects," "anticipates,"
"foresees," "hopes," "develops," "researching," "research,"
"potential," "could" or other words or phrases of similar import.
Similarly, statements in this release that describe the Company's
business strategy, outlook, objectives, plans, intentions or goals
should all be considered forward-looking statements. All such
forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially
from those in forward-looking statements. Management cautions that
its ability to further its research, and create commercially-viable
products may be affected by the competitive environment, the
Company's financial condition and its ability to raise sufficient
capital to meet the financial obligations of its business plan and
to fund its continuing operations.
Contact: Ben Hansel (720) 288-8495 Email Contact
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From May 2024 to Jun 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Jun 2023 to Jun 2024